Prevention by care and treatment of HIV-positive pregnant woman in Côte d'Ivoire by Prao, Kouamé Hervé Aka et al.
POSTER PRESENTATION Open Access
Prevention by care and treatment of HIV-positive
pregnant woman in Côte d’Ivoire
Kouamé Hervé Aka Prao
*, Nicole Dakoury, Pety Touré, Nafissa Diakité, Koko Régina Konan,
Marie-france Coulibaly Anaky, Siaka Touré, Irma Ahoba Bobo
From 16
th International Symposium on HIV and Emerging Infectious Diseases
Marseille, France. 24-26 March 2010
Background
Côte d’Ivoire is a west Africa country. With a HIV pre-
valence of 8.6% among pregnant women and 661,000
births per year, Cote d’Ivoire has an estimated 55,000
HIV-infected women delivering per year who need
PMTCT services. ACONDA’s extension of decentralized
prevention and care for pregnant women and PLWHA
is based on a health district approach.
Methods
Health workers were trained. After, the program strategy
consisted in coaching the care providers at the sites in
VCT techniques with rapid HIV testing for women with
unknown HIV status in ANC, labor-and-delivery rooms
and Family Planning unit also.
Drawing up and spreading simple technical proce-
dures helped the care providers in the implementation
of PMTCT.
The combined prophylaxis was offered to HIV-
infected pregnant women and their newborns systemati-
cally, as recommended by national program, and then
she got initial biological exams. Those who were eligible
received a readjusted treatment. Those who were ineligi-
ble continued the current disease prevention. A psycho-
social supports for treatment adherence, was provided
by counselors and Nutritional advices also. A child’s
early HIV diagnosis by PCR is made after 6 weeks of
postnatal follow up.
Results
From January through November 2008, PMTCT services
were integrated into 70 ANC clinics in urban areas and
20 in rural areas, covering 23 districts, with 100 trained
health workers. Of 54,876 pregnant women using
antenatal services, 45,730 (83.33%) received HIV coun-
seling and testing; 3100 (6.77%) were HIV-positive; and
3,000 infected pregnant women (96%) received their test
results. 78% of HIV-infected women received the
mother and child combined prophylaxis against 68% in
2007. Among the HIV-infected women, 520 were eligi-
ble for ART according to the WHO criteria.
Discussion
Providing the combined prophylaxis from the disclosure
of test results is essential if we noticeably want to
reduce the Mother to child HIV Transmission for the
scaling up. Without intervention in our country, the
rate of transmission is between 30-40 per cent.
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